Apoptosis and Disease Severity is Associated with Insulin Resistance in Nonalcoholic Fatty Liver Disease

被引:0
作者
Atay, Kadri [1 ]
Canbakan, Billur [1 ]
Koroglu, Emine [3 ]
Hatemi, Ibrahim [1 ]
Canbakan, Mustafa [4 ]
Kepil, Nuray [2 ]
Tuncer, Murat [1 ]
Senturk, Hakan [5 ]
机构
[1] Istanbul Univ, Cerrahpasa Fac Med, Div Gastroenterol, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Fac Med, Div Pathol, Istanbul, Turkey
[3] Dr Lutfi Kirdar Kartal Training & Res Hosp, Div Gastroenterol, Istanbul, Turkey
[4] Haydarpasa Numune Training & Res Hosp, Div Nephrol, TR-34668 Istanbul, Turkey
[5] Bezmialem Sch Med, Div Gastroenterol, Istanbul, Turkey
关键词
Apoptosis; insulin resistance fatty liver disease; NF-KAPPA-B; HEPATOCYTE APOPTOSIS; DEATH RECEPTORS; IN-VIVO; STEATOHEPATITIS; EXPRESSION; TNF; RESPONSES; CELLS; ACTIVATION;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims : Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance (IR). We evaluated whether IR contributes to hepatocyte apoptosis, inflammation, and fibrosis in NAFLD. Methods : Forty-four teetotaller patients with biopsy-proven diagnosis of NAFLD were enrolled. Twenty-eight NAFLD patients with IR were compared with 16 subjects without IR. For apoptotic activity caspase 3 and 8, transcription nuclear factor kB (NFkB), and anti-apoptotic Bcl-2 protein were determined through immunohistochemical methods. Results : HOMA-IR index was significantly correlated with the stage and caspase 3- and 8 levels (p= 0.001, 0.02, and 0.01, respectively). HOMA-IR index was independently associated with the severity of fibrosis (beta = 5.9, p = 0.001), caspase-3 (beta = 0.16 , p = 0.001), and caspase-8 (b = 0.032, p = 0.018) levels. TNF-sRp55 level was positively correlated with HOMA-IR index (p = 0.024). Patients with IR had significantly higher necroinflammatory grade, stage, caspase-3, and caspase-8 levels than those without IR (p = 0.022, 0.007, 0.031, and p = 0.011, respectively). HOMA-IR index had statistically significant values for distinguishing of severe necroinflammatory grade, stage and for differentiating NASH from simple fatty liver (AUC = 0.78, 0.76, and 0.82, respectively). Conclusion : This study demonstrates that IR in NAFLD is associated with enhanced hepatocyte apoptosis and histopathologic disease severity. These data indicate that NAFLD patients with IR may have increased risk for disease progression.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 47 条
[1]   Nonalcoholic fatty liver disease [J].
Adams, Leon A. ;
Lindor, Keith D. .
ANNALS OF EPIDEMIOLOGY, 2007, 17 (11) :863-869
[2]  
Akcali KC, 2004, WORLD J GASTROENTERO, V10, P279
[3]   Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis [J].
Anstee, Quentin M. ;
Concas, Danilo ;
Kudo, Hiromi ;
Levene, Adam ;
Pollard, John ;
Charlton, Peter ;
Thomas, Howard C. ;
Thursz, Mark R. ;
Goldin, Robert D. .
JOURNAL OF HEPATOLOGY, 2010, 53 (03) :542-550
[4]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[5]   The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis [J].
Barreyro, Fernando J. ;
Holod, Silvia ;
Finocchietto, Paola V. ;
Camino, Alejandra M. ;
Aquino, Jorge B. ;
Avagnina, Alejandra ;
Carreras, Maria C. ;
Poderoso, Juan J. ;
Gores, Gregory J. .
LIVER INTERNATIONAL, 2015, 35 (03) :953-966
[6]   Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it [J].
Begriche, K ;
Igoudjil, A ;
Pessayre, D ;
Fromenty, B .
MITOCHONDRION, 2006, 6 (01) :1-28
[7]   A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[8]   Non-alcoholic fatty liver disease and cardiovascular risk [J].
Brea, Angel ;
Puzo, Jose .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) :1109-1117
[9]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[10]  
Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x